Research suggests that prior infections with SARS-CoV-2 may provide some level of protection against future infections and severe disease. Studies have investigated the relationship between the number of prior infections and the level of protection acquired, with some focusing on specific variants such as Delta and Omicron. The effectiveness of infection-acquired protection, as well as the combined effects of vaccination and previous infection, are being examined in various populations, including children and adults.